Myeloid derived suppressor cells and innate immune system interaction in tumor microenvironment

被引:24
作者
Pramanik, Anik [1 ]
Bhattacharyya, Sankar [1 ]
机构
[1] Sidho Kanho Birsha Univ, Dept Zool, Immunobiol & Translat Med Lab, Purulia 723104, West Bengal, India
关键词
Chronic inflammation; Myeloid derived suppressor cells; NK cells; NKT cells; Regulatory T cells; Tumor associated macrophages; Tumor associated neutrophils; Tumor microenvironment (TME); ? T cells; NATURAL-KILLER-CELLS; REGULATORY T-CELLS; NITRIC-OXIDE SYNTHASE; NK CELLS; HEPATOCELLULAR-CARCINOMA; DENDRITIC CELLS; IFN-GAMMA; ANGIOGENIC SWITCH; CANCER-CELLS; TH17; CELLS;
D O I
10.1016/j.lfs.2022.120755
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The tumor microenvironment is a complex domain that not only contains tumor cells but also a plethora of other host immune cells. By nature, the tumor microenvironment is a highly immunosuppressive milieu providing growing conditions for tumor cells. A major immune cell population that contributes most in the development of this immunosuppressive microenvironment is the MDSC, a heterogenous population of immature cells. Although found in small numbers only in the bone marrow of healthy individuals, they readily migrate to the lymph nodes and tumor site during cancer pathogenesis. MDSC mediated disruption of antitumor T cell activity is a major cause of the immunosuppression at the tumor site, but recent findings have shown that MDSC mediated dysfunction of other major immune cells might also play an important role. In this article we will review how crosstalk with MDSC alters the activity of both conventional and unconventional immune cells that inhibits the antitumor immunity and promotes cancer progression.
引用
收藏
页数:13
相关论文
共 165 条
[1]   Inflammation and cancer: how friendly is the relationship for cancer patients? [J].
Aggarwal, Bharat B. ;
Gehlot, Prashasnika .
CURRENT OPINION IN PHARMACOLOGY, 2009, 9 (04) :351-369
[2]   Prognostic role of myeloid-derived suppressor cells in cancers: a systematic review and meta-analysis [J].
Ai, Lisha ;
Mu, Shidai ;
Wang, Yadan ;
Wang, Huafang ;
Cai, Li ;
Li, Wenzhu ;
Hu, Yu .
BMC CANCER, 2018, 18
[3]   Doxorubicin Eliminates Myeloid-Derived Suppressor Cells and Enhances the Efficacy of Adoptive T-Cell Transfer in Breast Cancer [J].
Alizadeh, Darya ;
Trad, Malika ;
Hanke, Neale T. ;
Larmonier, Claire B. ;
Janikashvili, Nona ;
Bonnotte, Bernard ;
Katsanis, Emmanuel ;
Larmonier, Nicolas .
CANCER RESEARCH, 2014, 74 (01) :104-118
[4]   Increased production of immature myeloid cells in cancer patients: A mechanism of immunosuppression in cancer [J].
Almand, B ;
Clark, JI ;
Nikitina, E ;
van Beynen, J ;
English, NR ;
Knight, SC ;
Carbone, DP ;
Gabrilovich, DI .
JOURNAL OF IMMUNOLOGY, 2001, 166 (01) :678-689
[5]   Blockade of Myeloid-Derived Suppressor Cell Expansion with All-Trans Retinoic Acid Increases the Efficacy of Antiangiogenic Therapy [J].
Bauer, Raimund ;
Udonta, Florian ;
Wroblewski, Mark ;
Ben-Batalla, Isabel ;
Santos, Ines Miranda ;
Taverna, Federico ;
Kuhlencord, Meike ;
Gensch, Victoria ;
Paesler, Sarina ;
Vinckier, Stefan ;
Brandner, Johanna M. ;
Pantel, Klaus ;
Bokemeyer, Carsten ;
Vogl, Thomas ;
Roth, Johannes ;
Carmeliet, Peter ;
Loges, Sonja .
CANCER RESEARCH, 2018, 78 (12) :3220-3232
[6]   Coinhibitory Pathways in Immunotherapy for Cancer [J].
Baumeister, Susanne H. ;
Freeman, Gordon J. ;
Dranoff, Glenn ;
Sharpe, Arlene H. .
ANNUAL REVIEW OF IMMUNOLOGY, VOL 34, 2016, 34 :539-573
[7]   Tumor-Derived Granulocyte-Macrophage Colony-Stimulating Factor Regulates Myeloid Inflammation and T Cell Immunity in Pancreatic Cancer [J].
Bayne, Lauren J. ;
Beatty, Gregory L. ;
Jhala, Nirag ;
Clark, Carolyn E. ;
Rhim, Andrew D. ;
Stanger, Ben Z. ;
Vonderheide, Robert H. .
CANCER CELL, 2012, 21 (06) :822-835
[8]  
Bellocq A, 1998, AM J PATHOL, V152, P83
[9]   CD1 RECOGNITION BY MOUSE NK1(+) T-LYMPHOCYTES [J].
BENDELAC, A ;
LANTZ, O ;
QUIMBY, ME ;
YEWDELL, JW ;
BENNINK, JR ;
BRUTKIEWICZ, RR .
SCIENCE, 1995, 268 (5212) :863-865
[10]   Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis [J].
Bergers, G ;
Brekken, R ;
McMahon, G ;
Vu, TH ;
Itoh, T ;
Tamaki, K ;
Tanzawa, K ;
Thorpe, P ;
Itohara, S ;
Werb, Z ;
Hanahan, D .
NATURE CELL BIOLOGY, 2000, 2 (10) :737-744